What to expect as a study volunteer.
A plain-language walkthrough of a bioequivalence or early-phase study — from screening and informed consent to washout, dosing, compensation and site rules. This is general information, not medical advice; the study protocol and the site investigator always take precedence.
What is a clinical study?
A clinical study — often a bioequivalence (BA/BE) study — compares a new medicine against an existing reference medicine. Volunteers stay at a study centre for a defined period, and clinical staff collect blood samples at set time points to measure how the medicine behaves in the body.
Medical screening
Before any study you undergo a full medical check-up called screening. It typically includes:
- BMI check (commonly accepted range around 18.5–30.0, set by the study protocol)
- Blood pressure, pulse and temperature
- Blood and urine samples
- ECG, and sometimes a chest X-ray
- Identity confirmation via photo and biometric checks at the site
Informed consent (ICF / ICD)
The Informed Consent Form or Document is a legal document describing the study in full. The site must give it to you to read before you join. It covers:
- Purpose and duration of the study
- Potential risks and side effects of the medicine
- Your rights, including the right to withdraw at any time
- Contact details of the doctors responsible for your safety
Study periods, rounds and washout
A study is usually divided into periods (rounds). Each period has a check-in, a dosing day and a checkout. The gap between periods is the washout period, which lets the previous dose clear your system before the next one.
Stay and facilities
During your stay the centre provides food, clothing and toiletries. Personal items are usually restricted. Most centres offer TV, board games and similar recreation. Some allow basic phones; many do not permit smartphones inside the ward.
Diet and habits
Studies may be conducted fed (a standard meal is provided before dosing) or fasting (no meal). If you use tobacco, alcohol or any medication, you must tell the doctor at screening. Using them during the study is not allowed.
Medical staff and care
Qualified nurses collect samples around the clock, and doctors are available 24/7 for check-ups and for anything that affects your safety during the study.
The dosing process
On dosing day a cannula is often placed in your arm so samples can be collected without repeated pricks. Sites usually restrict water and washroom use for a short window before and after dosing — follow the instructions given by the study staff.
Blood samples and ambulatory visits
Samples are drawn at protocol-defined time points, all counted from the moment of dosing. After checkout you may need to return to the centre for ambulatory samples; these visits are part of the study and must be attended on time.
Compensation and payment cycle
Sites compensate you for your time, including a screening-day allowance in many cases even if you are not selected. Study compensation is often paid partly after each period, with the balance cleared after the final safety sample. Amounts are set by the site and the protocol, never by Clinical Study Passport.
Important rules
- No tea, coffee, smoking or alcohol for at least 24 hours before screening or dosing
- Arrive on time for check-in (usually early morning for the first period)
- Sites may run alcohol or nicotine tests before sampling
- Declare recent participation and dosing dates honestly — washout matters for your safety
Your Clinical Study Passport keeps your identity, eligibility profile and participation history in one place, so interval and washout signals travel with you between centres — only when you consent. Screening results and clinical records stay with the site that created them. Final eligibility is always the investigator's decision.
Compensation figures, screening criteria and ward rules vary by site, city and protocol. Always confirm details with the study centre and read the informed consent document before agreeing to participate.